Evaluation of minimal residual disease using next generation flow cytometry in patients with AL amyloidosis

被引：0
|
作者：
Kastritis, Efstathios [1 ]
Fotiou, Despina [2 ]
Kostopoulos, Ioannis [1 ]
Theodorakakou, Foteini [1 ]
Terpos, Evangelos [1 ]
Gavriatopoulou, Maria [3 ]
Spiliopoulou, Vasiliki [3 ]
Ntanasis-Stathopoulos, Ioannis [3 ]
Malandrakis, Panagiotis [1 ]
Kanellias, Nikolaos [3 ]
Roussou, Maria [1 ]
Magdalini, Migkou [4 ]
Eleutherakis-Papaiakovou, Evangelos [3 ]
Solia, Eirini [2 ]
Papathoma, Alexandra [4 ]
Tsitsilonis, Ourania [3 ]
Dimopoulos, Meletios Athanasios
机构：
[1] Ethniko Kai Kapodistriako Panepistemio Athenon, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Athens, Greece
[4] Natl & Kapodistrian Univ Athens, Alexandra Hosp, Dept Oncol, Dept Clin Therpaeut,Sch Med, Athens, Greece
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
156
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [21] Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet?
    Lee, H.
    Duggan, P.
    Neri, P.
    Tay, J.
    Bahlis, N. J.
    Jimenez-Zepeda, V. H.
    BONE MARROW TRANSPLANTATION, 2017, 52 (06) : 915 - 917
  • [22] Assessment of Minimal Residual Disease in AL-Amyloidosis by Multiplex Immunohistochemistry: A Comparative Analysis with Multiparametric Flow Cytometry
    Li, Julie
    Choksi, Sanket
    Connors, Lawreen
    Staron, Andrew
    Sanchorawala, Vaishali
    Burks, Eric
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 976 - 977
  • [23] Assessment of Minimal Residual Disease in AL-Amyloidosis by Multiplex Immunohistochemistry: A Comparative Analysis with Multiparametric Flow Cytometry
    Li, Julie
    Choksi, Sanket
    Connors, Lawreen
    Staron, Andrew
    Sanchorawala, Vaishali
    Burks, Eric
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 976 - 977
  • [24] Prognostic significance of circulating tumor cells assessed with next generation flow cytometry in patients with AL amyloidosis
    Kastritis, Efstathios
    Kostopoulos, Ioannis V.
    Fotiou, Despina
    Terpos, Evangelos
    Theodorakakou, Foteini
    Rousakis, Pantelis
    Angelis, Nikolaos V.
    Gavriatopoulou, Maria
    Spiliopoulou, Vasiliki
    Panteli, Chrysanthi
    Ntanasis-Stathopoulos, Ioannis
    Malandrakis, Panagiotis
    Kanellias, Nikolaos
    Roussou, Maria
    Migkou, Magdalini
    Eleutherakis-Papaiakovou, Evangelos
    Solia, Eirini
    Papathoma, Alexandra
    Tsitsilonis, Ourania
    Dimopoulos, Meletios Athanasios
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S237 - S237
  • [25] Longitudinal Assessment and Prognostic Importance of Minimal Residual Disease (MRD) By Multiparametric Flow Cytometry in Patients with Systemic Light Chain (AL) Amyloidosis
    Staron, Andrew
    Burks, Eric
    Sanchorawala, Vaishali
    BLOOD, 2021, 138 : 3767 - +
  • [26] Clinical Implication of Minimal Residual Disease By Multiparameter Flow Cytometry in Light Chain Amyloidosis
    Xu, Tianhong
    Li, Jing
    Yang, Yang
    Wang, Wenjing
    Wang, Pu
    Yu, Chenqi
    Liu, Peng
    BLOOD, 2023, 142
  • [27] Comparison of Next-Generation Flow Cytometry (NGF) and Next-Generation Sequencing (NGS) in the Assessment of Minimal Residual Disease in Multiple Myeloma
    Wang, Qingqing
    Yao, Li
    Zhu, Mingqing
    Yan, Lingzhi
    Jin, Song
    Shang, Jingjing
    Shi, Xiaolan
    Zhai, Yingying
    Yan, Shuang
    Yao, Weiqin
    You Hongying
    Wu, Depei
    Fu, Chengcheng
    BLOOD, 2022, 140 : 7249 - 7250
  • [28] Flow cytometry for the evaluation of minimal residual disease in acute lymphoblastic leukemia
    Juarez-Velazquez, Rocio
    Perez-Vera, Patricia
    ACTA PEDIATRICA DE MEXICO, 2012, 33 (04): : 198 - 206
  • [29] Persistence of Minimal Residual Disease By Multiparameter Flow Cytometry Can Hinder Recovery of Organ Damage in Patients with AL Amyloidosis Otherwise in Complete Response
    Palladini, Giovanni
    Massa, Margherita
    Basset, Marco
    Russo, Francesca
    Milani, Paolo
    Foli, Andrea
    Merlini, Giampaolo
    BLOOD, 2016, 128 (22)
  • [30] "Friends and foes" of multiple myeloma measurable/minimal residual disease evaluation by next generation flow
    Pacelli, Paola
    Raspadori, Donatella
    Bestoso, Elena
    Gozzetti, Alessandro
    Bocchia, Monica
    FRONTIERS IN ONCOLOGY, 2022, 12
12345